Orchestra BioMed Holdings, Inc. (OBIO)
Total Valuation
OBIO has a market cap or net worth of $189.62 million. The enterprise value is $103.71 million.
Market Cap | 189.62M |
Enterprise Value | 103.71M |
Important Dates
The last earnings date was Wednesday, March 27, 2024, after market close.
Earnings Date | Mar 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
OBIO has 35.74 million shares outstanding. The number of shares has increased by 121.67% in one year.
Shares Outstanding | 35.74M |
Shares Change (YoY) | +121.67% |
Shares Change (QoQ) | -0.29% |
Owned by Insiders (%) | 37.30% |
Owned by Institutions (%) | 36.84% |
Float | 19.44M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 68.70 |
Forward PS | 79.30 |
PB Ratio | 2.79 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 37.58 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.95, with a Debt / Equity ratio of 0.02.
Current Ratio | 7.95 |
Quick Ratio | 7.82 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -58.30% and return on invested capital (ROIC) is -73.86%.
Return on Equity (ROE) | -58.30% |
Return on Assets (ROA) | -41.50% |
Return on Capital (ROIC) | -73.86% |
Revenue Per Employee | $690,000 |
Profits Per Employee | -$12.28M |
Employee Count | 4 |
Asset Turnover | 0.02 |
Inventory Turnover | 0.88 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.41% in the last 52 weeks. The beta is 0.18, so OBIO's price volatility has been lower than the market average.
Beta (1Y) | 0.18 |
52-Week Price Change | -66.41% |
50-Day Moving Average | 6.57 |
200-Day Moving Average | 6.93 |
Relative Strength Index (RSI) | 38.57 |
Average Volume (30 Days) | 52,990 |
Short Selling Information
The latest short interest is 876,400, so 2.45% of the outstanding shares have been sold short.
Short Interest | 876,400 |
Short Previous Month | 900,986 |
Short % of Shares Out | 2.45% |
Short % of Float | 4.51% |
Short Ratio (days to cover) | 19.36 |
Income Statement
In the last 12 months, OBIO had revenue of $2.76 million and -$49.12 million in losses. Loss per share was -$1.48.
Revenue | 2.76M |
Gross Profit | 2.57M |
Operating Income | -51.51M |
Pretax Income | -49.12M |
Net Income | -49.12M |
EBITDA | -48.20M |
EBIT | -49.12M |
Loss Per Share | -$1.48 |
Balance Sheet
The company has $87.60 million in cash and $1.69 million in debt, giving a net cash position of $85.91 million or $2.40 per share.
Cash & Cash Equivalents | 87.60M |
Total Debt | 1.69M |
Net Cash | 85.91M |
Net Cash Per Share | $2.40 |
Equity / Book Value | 68.04M |
Book Value Per Share | 1.90 |
Working Capital | 77.91M |
Cash Flow
In the last 12 months, operating cash flow was -$46.13 million and capital expenditures -$78,000, giving a free cash flow of -$46.21 million.
Operating Cash Flow | -46.13M |
Capital Expenditures | -78,000 |
Free Cash Flow | -46.21M |
FCF Per Share | -$1.39 |
Margins
Gross margin is 93.26%, with operating and profit margins of -1,866.16% and -1,779.71%.
Gross Margin | 93.26% |
Operating Margin | -1,866.16% |
Pretax Margin | -1,779.71% |
Profit Margin | -1,779.71% |
EBITDA Margin | -1,746.41% |
EBIT Margin | -1,779.71% |
FCF Margin | -1,674.09% |
Dividends & Yields
OBIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -121.67% |
Shareholder Yield | -121.67% |
Earnings Yield | -25.90% |
FCF Yield | -24.37% |
Analyst Forecast
The average price target for OBIO is $17.00, which is 222.58% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $17.00 |
Price Target Difference | 222.58% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
OBIO has an Altman Z-Score of -0.16 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.16 |
Piotroski F-Score | 3 |